Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

GLAXOSMITHKLINE PLC (GSK)

133
Delayed Quote. Delayed London Stock Exchange - 09/01 11:35:01 am
1460 GBp   -0.98%
12h ago CIPLA : launches copy of GSK's top asthma drug in Germany, Sweden
3d ago GLAXOSMITHKLINE : Assigned Patent
4d ago GLAXOSMITHKLINE : Ebola vaccine trials fast-tracked by international consor..
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 

GlaxoSmithKline: European Commission Authorizes Nimenix

04/27/2012 | 08:24am US/Eastern
Recommend:
0

GlaxoSmithKline PLC (>> GlaxoSmithKline plc), the drug company, said Friday that the European Commission has granted marketing authorization for Nimenrix, Meningococcal group A, C, W-135 and Y conjugate vaccine, for active immunization against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W-135 and Y.

-Shares at 1207 GMT, up a penny, or 0.04%, at 1,420.5 pence valuing the company at GBP71.61 billion.

-By Rory Gallivan, Dow Jones Newswires; 44-20-7842-9411; rory.gallivan@dowjones.com

Stocks mentioned in the article : GlaxoSmithKline plc
Recommend :
0
React to this article
Latest news on GLAXOSMITHKLINE PLC
12h ago CIPLA : launches copy of GSK's top asthma drug in Germany, Sweden
3d ago GLAXOSMITHKLINE : Assigned Patent
4d ago GLAXOSMITHKLINE : Ebola vaccine trials fast-tracked by international consortium
4d ago GLAXOSMITHKLINE : GSK receives FDA approval for Arnuity™ Ellipta® fluticas..
4d ago GLAXOSMITHKLINE : GSK Gets FDA Approval for Arnuity Ellipta (fluticasone furoate..
5d ago GLAXOSMITHKLINE : Glaxo Says FDA Approves Promacta SNDA In Aplastic Anaemia Pati..
6d ago GLAXOSMITHKLINE : Triumeq US Approval
08/25 GLAXOSMITHKLINE : *socgen raises glaxosmithkline price target to 1920 pence - 'b..
08/22 GLAXOSMITHKLINE : ViiV Healthcare receives FDA approval for Triumeq® (abacavir, ..
08/21 Healthcare stocks lift FTSE 100
Advertisement
Chart
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Income Statement Evolution
GlaxoSmithKline plc : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF